Skip to main content
Download PDF

Correction: Recognition and stigma of prescription drug abuse disorder: personal and community determinants

BMC Public Health volume 23, Article number: 2049 (2023) Cite this article

The Original Article was published on 22 June 2020

BMC Public Health (2020) 20:977

https://doi.org/10.1186/s12889-020-09063-z

The original publication of this article contained an incorrect exemption statement in the method section. The incorrect and correct information is listed in this correction article.

Incorrect:

The Prescription Drug Abuse survey took place between July 6 and July 16, 2016 (IRB approved October 1, 2014 by Michigan State University Human Research Protection Program).

Correct:

The Prescription Drug Abuse survey took place between July 6 and July 16, 2016 (IRB approved as exempt October 1, 2014 by Michigan State University Human Research Protection Program).

Author information

Authors and Affiliations

  1. Department of Agricultural, Food and Resource Economics, Michigan State University, East Lansing, MI, 48824, USA

    Robert Shupp, Scott Loveridge & Mark Skidmore

  2. JG Research & Evaluation, 2103 Bridger Drive, Suite 1, Bozeman, MT, 59715, USA

    Brandn Green

  3. Western Rural Development Center, Utah State University, 4880 Old Main Hill, Logan, UT, 84322, USA

    Don Albrecht

Authors
  1. Robert Shupp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Loveridge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark Skidmore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brandn Green
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Don Albrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert Shupp.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s12889-020-09063-z

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shupp, R., Loveridge, S., Skidmore, M. et al. Correction: Recognition and stigma of prescription drug abuse disorder: personal and community determinants. BMC Public Health 23, 2049 (2023). https://doi.org/10.1186/s12889-023-16802-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12889-023-16802-5

BMC Public Health

ISSN: 1471-2458

Contact us